Stopping aspirin therapy after GI bleed ups cardiovascular risk

Stopping aspirin therapy after GI bleed ups cardiovascular risk
Patients with cardiovascular disease who discontinue low-dose aspirin therapy after peptic ulcer bleeding have a seven-fold higher risk of death or acute cardiovascular event, according to research published in the January issue of Clinical Gastroenterology and Hepatology.

(HealthDay)—Patients with cardiovascular disease who discontinue low-dose aspirin therapy after peptic ulcer bleeding have a seven-fold higher risk of death or acute cardiovascular event, according to research published in the January issue of Clinical Gastroenterology and Hepatology.

Maryam Derogar, of the Karolinska Institutet in Stockholm, and colleagues conducted a using data from 621 patients who had been admitted due to . The authors sought to determine how patient mortality and acute cardiovascular events are affected when patients discontinue low-dose aspirin therapy after peptic ulcer bleeding.

The researchers found that, in total, 118 patients among those admitted for upper gastrointestinal bleeding were taking low-dose aspirin therapy. Of these, 40 percent discontinued aspirin therapy after peptic ulcer bleeding. During a median of two years of follow-up, 37 percent of all patients who had been taking low-dose aspirin prior to gastrointestinal bleeding died or experienced an acute cardiovascular event. After adjusting for potential confounders, the risk of death or acute was 6.9-fold higher for those who discontinued low-dose aspirin therapy, compared with those patients who continued aspirin therapy within the first six months after peptic ulcer bleeding.

"In conclusion, in patients with cardiovascular comorbidities who are treated for peptic ulcer bleeding, aspirin therapy should not be discontinued at the time of discharge from hospital," the authors write.

More information: Abstract
Full Text

Related Stories

Even low-dose aspirin may increase risk of GI bleeding

date Sep 12, 2011

The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. According to a new study in Clinical Ga ...

Aspirin, acid blocker a-day keeps GI bleeding

date Aug 11, 2008

For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal ...

Recommended for you

1950s drug is future heart treatment

date 24 minutes ago

Oxford University researchers have found a promising future treatment for heart disease, going back to a drug first developed in 1950.

Time is muscle in acute heart failure

date 10 hours ago

Urgent diagnosis and treatment in acute heart failure has been emphasised for the first time in joint recommendations published today in European Heart Journal.

Common mutation linked to heart disease

date May 20, 2015

A common mutation in a gene that regulates cholesterol levels may raise the risk of heart disease in carriers, according to a new UConn Health study.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.